跳至主要内容
临床试验/NCT04423484
NCT04423484招募中不适用

Therapeutic Recommendations for the Treatment of Children With Nephroblastoma in Africa.

French Africa Pediatric Oncology Group7 个研究点 分布在 6 个国家目标入组 1,000 人开始时间: 2020年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000
试验地点
7
主要终点
Evaluation of the number of cases with stage IV disease.

研究概览

简要总结

The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.

详细描述

The study is based on results form 2 previous studies carried out by the GFAOP. This study aims to evaluate the capacity of units to follow the recommendations in the protocol. It will look mainly at treatment compliance and outcome for the children treated. The study will also evaluate the improvement in treatment compliance and reporting. This work will help the group to evaluate future needs in participating units and help us adapt treatment programmes to local conditions.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
6 Months 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Unilateral Nephroblastoma Tumor Not previously treated The general health of the child will permit treatment.

排除标准

  • Bilateral Nephroblastoma tumor Previously treated Disease too advanced Doubt concerning the diagnosis Treatment Refusal

结局指标

主要结局

Evaluation of the number of cases with stage IV disease.

时间窗: 5 Years

By evaluating the initial clinical reports and later histological reports to confirm the stage.

Evaluating the treatment given.

时间窗: 5 Years

Comparison of treatment given and recommended treatment.

Evaluation of the number of cases with local disease.

时间窗: 5 years

By evaluating the initial clinical reports and later histological reports to confirm the stage and the diagnosis.

Evaluating the follow up after treatment.

时间窗: 5 Years

How many children alive or dead after treatment

次要结局

  • Why has treatment failed(5 years)

研究者

发起方
French Africa Pediatric Oncology Group
申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验

Therapeutic Recommendations for Nephroblastoma | 临床试验